Prolongation of radiotherapy duration is associated with inferior overall survival in patients with pediatric medulloblastoma and central nervous system primitive neuroectodermal tumors.
Sujith BaligaBenjamin V M BajajRafi KabarritiClemens GrassbergerBrooke PattesonBeow YeapJana L FoxMadhur K GargTorunn I YockPublished in: Pediatric blood & cancer (2020)
For patients with high-risk medulloblastoma and CNS PNETs, RT duration >45 days was associated with inferior OS.